Hallam Thomas 4
4 · PALISADE BIO, INC. · Filed Aug 18, 2022
Insider Transaction Report
Form 4
Hallam Thomas
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock, par value $0.01
2022-08-16$0.25/sh+40,000$10,000→ 57,592 total - Purchase
Series 1 Common Stock Purchase Warrant
2022-08-16+40,000→ 40,000 totalExercise: $0.25Exp: 2023-08-16→ Common Stock (40,000 underlying) - Purchase
Series 2 Common Stock Purchase Warrant
2022-08-16+40,000→ 40,000 totalExercise: $0.25Exp: 2027-08-16→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Represents common shares underlying 40,000 Units of Issuer purchased by Reporting Person ("Units") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25.
- [F2]Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.
- [F3]Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.